Association of vascular endothelial growth factor (VEGF) protein levels and gene polymorphism with the risk of chronic kidney disease

References

• Santana Machado T, Cerini C, Burtey S. Emerging roles of aryl hydrocarbon receptors in the altered clearance of drugs during chronic kidney disease. Toxins (Basel). 2019;11(4):209.
   PubMed Web of Science ®Google Scholar
• Yang M, Zou Y, Lu T, et al. Revised equations to estimate glomerular filtration rate from serum creatinine and cystatin C in China. Kidney Blood Press Res. 2019;44(4):1–7.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Bolton K. et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
   PubMed Web of Science ®Google Scholar
• Annaldas S, Saifi M, Khurana A, et al. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling. Mol Immunol. 2019;112:247–255.
   PubMed Web of Science ®Google Scholar
• George C, Yako Y, Okpechi I, et al. An African perspective on the genetic risk of chronic kidney disease: a systematic review. BMC Med Gene. 2018;19(1):187.
   PubMedGoogle Scholar
• Khodeir SA, Okda HI, Abdalal HM. Clinical significance of fibroblast growth factor-23 and soluble alpha klotho in different stages of chronic kidney disease. Saudi J Kidney Dis Transpl. 2019;30(1):108–118.
   PubMed Web of Science ®Google Scholar
• Suassuna PGA, de Paula RB, Sanders-Pinheiro H, et al. Fibroblast growth factor 21 in chronic kidney disease. J Nephrol. 2019;32(3):365–377.
   PubMed Web of Science ®Google Scholar
• Yang W, Wang J, Shi L, et al. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats. Cytokine. 2012;59(2):370–376.
   PubMed Web of Science ®Google Scholar
• Sato W, Kosugi T, Zhang L, et al. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy. Lab Invest. 2008;88(9):949–961. DOI:10.1038/labinvest.2008.60
   PubMed Web of Science ®Google Scholar
• Hasegawa S, Nakano T, Torisu K, et al. Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction. Lab Invest. 2017;97(12):1439–1452.
   PubMed Web of Science ®Google Scholar
• Melincovici C, Bosca A, Susman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–467.
   PubMed Web of Science ®Google Scholar
• Boon-Peng H, Mat Jusoh JA, Marshall CR, et al. Rare copy number variants identified suggest the regulating pathways in hypertension-related left ventricular hypertrophy. PLoS ONE. 2016;11(3):e0148755.
   PubMed Web of Science ®Google Scholar
• Hollox EJ, Hoh BP. Human gene copy number variation and infectious disease. Hum Genet. 2014;133(10):1217–1233.
   PubMed Web of Science ®Google Scholar
• Asanghanwa M, Gorus FK, Weets I, et al. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients. Diabetes Res Clin Pract. 2014;103(1):97–105. DOI:10.1016/j.diabres.2013.11.013
   PubMed Web of Science ®Google Scholar
• Mbunwe E, Van der Auwera BJ, Vermeulen I, et al. HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients. Diabetes. 2013;62(4):1345–1350. DOI:10.2337/db12-0747
   PubMed Web of Science ®Google Scholar
• Zhou T, Li H, Zhong H, et al. Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population. BMC Med Gene. 2018;19(1):201.
   PubMedGoogle Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Futrakul P. A mildly altered vascular homeostasis in early stage of CKD. Ren Fail. 2009;31(7):538–543.
   PubMed Web of Science ®Google Scholar
• Jie KE, Zaikova MA, Bergevoet MW, et al. Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol Dialysis Transplantation. 2010;25(6):1875–1882. official publication of the European Dialysis and Transplant Association - European Renal Association. DOI:10.1093/ndt/gfp749
   PubMed Web of Science ®Google Scholar
• Thethi I, Bansal V, Khan H, et al. Assessment of levels of vascular endothelial growth factor in patients with ESRD and its possible role in cardiovascular morbidity and mortality. Clin Appl Thromb Hemost. 2012;18(5):534–537.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Ulazka B, Mysliwiec M, et al. Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Transl Res. 2012;160(5):346–354.
   PubMed Web of Science ®Google Scholar
• Chen YT, Cheng BC, Ko SF, et al. Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(1):83–91. DOI:10.1007/s10157-012-0664-9
   PubMed Web of Science ®Google Scholar
• Kacso IM, Kacso G. Endothelial cell-selective adhesion molecule in diabetic nephropathy. Eur J Clin Invest. 2012;42(11):1227–1234.
   PubMed Web of Science ®Google Scholar
• Hamed EA, El-Abaseri TB, Mohamed AO, et al. Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study. BMC Nephrol. 2012;13(1):136.
   PubMedGoogle Scholar
• Sahutoglu T, Sakaci T, Hasbal NB, et al. Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease. Medicine. 2017;96(18):e6543. DOI:10.1097/MD.0000000000006543
   PubMed Web of Science ®Google Scholar
• Anderson CE, Hamm LL, Batuman G, et al. The association of angiogenic factors and chronic kidney disease. BMC Nephrol. 2018;19(1):117. DOI:10.1186/s12882-018-0909-2
   PubMedGoogle Scholar
• Erturk I, Yesildal F, Acar R, et al. Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease. Associations with laboratory findings, comorbidities, and medications. Saudi Med J. 2018;39(6):586–591.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Pawlak D, Mysliwiec M. Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease. Am J Nephrol. 2004;24(6):635–640.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Pawlak D, Mysliwiec M. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Clin Biochem. 2007;40(1–2):81–85.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Mysliwiec M, Pawlak D. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. Cytokine. 2008;43(1):98–101.
   PubMed Web of Science ®Google Scholar
• Doi K, Noiri E, Nakao A, et al. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol. 2006;17(3):823–830.
   PubMed Web of Science ®Google Scholar
• Prakash S, Prasad N, Sharma RK, et al. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease. Cytokine. 2012;58(2):261–266.
   PubMed Web of Science ®Google Scholar